Mecontium ileus and Distal ileal obstructive syndrome (DIOS) (also known as meconium ileus equivalent) are bowel blockages due to abnormal, thick, tenacious stool. These obstructions are seen an a subset of patients with cystic fibrosis.
Meconium Ileus
- • Present in 20% of newborns with cystic fibrosis and may be the first clinical manifestation.
- • Abdominal distention at birth, multiple doughy loops of dilated bowel on palpation, bilious emesis, and failure to pass meconium in the first 24-48 hours of life.
- • Neuhauser’s sign
2 Types: complicated and uncomplicated
- • Uncomplicated: simple obstruction of terminal ileum
- • Complicated: volvulus, gangrene, atresia, or perforation (meconium peritonitis).
In uncomplicated meconium ileus, contrast enema can be both diagnostic and therapeutic. (Adding an emulsifying agent (Tween 80) may enhance effectiveness). Therapeutic enemas are 40-60% effective in patients with simple meconium ileus. The risk of perforation is approximately 3%. Perforation requires operative intervention. Simple end-to-end anastomosis is preferred because the long term surgical morbidity is lower than with enterostomy. Enterostomy or T-tube enterostomy is still acceptable and preferred in some centers.
- • Survival rates 80-90%.
- • 20 % develope meconium ileus equivalent later in life
- • 7% developed fibrosing colonopathy (may be lower now)
- • Small risk of mechanical small bowel obstructions later in life which may be difficult to distinguish from DIOS.
- • After 2 failed attempts of nonoperative hypertonic washout, operative intervention is may be indicated.
- • Enterotomy and intraoperative saline irrigation for mechanical seperation of the pellets from the bowel wall and evacuation of the meconium.
Distal Ileal Obstructive Syndrome
- • In one study, 12 % of patients with CF were affected. The majority had meconium ileus as an infant.
- • Frequently brought on by cessation of pancreatic enzyme replacement, dietary indiscretions, dehydration, or colds.
- • Conservative therapy preferred, but 26% of patients in one study required operation.
- • Autosomal recessive
- • Usually presents clinically as pancreatic insufficiency or chronic pulmonary disease
- • Advances in neonatal critical care, antibiotics, and anesthesia have allowed CF patients to survive longer.
- • Genetic studies – Delta F508 mutation associated with abdominal complaints rather than pulmonary complaints.
- • 25% of patients with meconium plug syndrome had CF
- • Chronic antibiotic use for assoc. pulmonary infections may mask the classic signs and symptoms of appendicitis.
- • Incidence of perforated appendix at time of diagnosis higher than for general population.
- • Result of colonic strictures and classically associated with high strength pancreatic enzyme replacement.
- • Gross appearance of the affected colon: The lumen is thickened and narrow. The mucosa has an erythematous cobblestone appearance.
- • 89% required operation.
- • 6% incidence in one series, but reported to occur in up to 23% of the CF population.
- • Occurs most commonly between the ages of 6 months to 3 years.
- • Most managed conservatively by manual reduction.
- • Surgical repair indicated for significant bleeding, incarcerated prolapse, severe pain, or failure of medical management.
- High incidence of inguinal hernia in the CF population.
- Chronic cough and poor nutrition may contribute
- Recurrence
- • Tube thoracostomy or pleurodesis for pneumothorax, lobar or wedge resection for bronchiectasis, and lung transplantation.
- • High mortality rate in CF patients with PTX, and high prevalence of history of PTX in those patients who died.
- • Lung transplant only therapy available for those with end stage lung disease.
- • The donor lung does not carry the CFTR gene.
- • Mortality rate was 27%
- • May aggravate FTT, adversely affect pulmonary function, and may account for the high incidence of CF lung disease in RLL
- • Theophylline
- • Incidence aprox. 81% in patients younger than 5 years old.
- • Children unresponsive to conservative therapy should have Nissen.
- • Gastrostomy tube
- • Pyloroplasty
- • Aprox. 1% of patients with CF.
- • Average age 9.5 years old
- • General pediatric population is 6-18 months
- • Abnormally thick stools adhere to the bowel wall and may act as a lead point.
- • Pediatric Surgeons
- • PulmonarySpecialists at a CF Center
- • Critical care specialists
- • Respiratory care specialists
- • Nutrition support specialists
- • Improved antibiotic and pancreatic enzyme therapy.